erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Skin Neoplasms D012878 12 associated lipids
Pleurisy D010998 20 associated lipids
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Osteitis D010000 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Osteolysis D010014 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Lengyel C et al. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia]. 1997 Orv Hetil pmid:9153994
Ehrmann EH Infective endocarditis and practical guides for successful dentistry. 1997 Aust Dent J pmid:9153847
McDonald PJ et al. Studies on absorption of a newly developed enteric-coated erythromycin base. 1977 J Clin Pharmacol pmid:915024
Colburn WA et al. Pharmacokinetics of erythromycin on repetitive dosing. 1977 J Clin Pharmacol pmid:915023
Watts JL and Salmon SA Activity of selected antimicrobial agents against strains of Staphylococcus aureus isolated from bovine intramammary infections that produce beta-lactamase. 1997 J. Dairy Sci. pmid:9149974
Panhuyzen-Goedkoop NM and Crijns HJ [Iatrogenic collapse; can this be prevented?]. 1997 Ned Tijdschr Geneeskd pmid:9148161
Barrett MS and Jones RN Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates. 1996 Diagn. Microbiol. Infect. Dis. pmid:9147907
Kendall BJ et al. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9146779
Schülin T et al. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. 1997 Antimicrob. Agents Chemother. pmid:9145901
Ross JI et al. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. 1997 Antimicrob. Agents Chemother. pmid:9145890
Ednie LM et al. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. 1997 Antimicrob. Agents Chemother. pmid:9145864
Sturm AW et al. Over-the-counter availability of antimicrobial agents, self-medication and patterns of resistance in Karachi, Pakistan. 1997 J. Antimicrob. Chemother. pmid:9145830
Wise R et al. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. 1997 J. Antimicrob. Chemother. pmid:9145816
Ng PC et al. Erythromycin treatment for gastrointestinal dysmotility in preterm infants. 1997 J Paediatr Child Health pmid:9145359
Tsuruta S et al. Effects of erythromycin, clarithromycin and rokitamycin on nifedipine metabolism in rats. 1997 Biol. Pharm. Bull. pmid:9145220
Cucchiara S et al. Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility. 1997 J. Pediatr. Gastroenterol. Nutr. pmid:9144124
Knothe H Medical implications of macrolide resistance and its relationship to the use of tylosin in animal feeds. 1977 Infection pmid:914361
Tanaka T et al. A new method to measure gastric emptying in conscious dogs: a validity study and effects of EM523 and L-NNA. 1997 Am. J. Physiol. pmid:9142925
García-Martos P et al. Increase in high resistance to penicillin of clinical isolates of Streptococcus pneumoniae in Cádiz, Spain. 1997 May-Jun Chemotherapy pmid:9142458
Florez C et al. Susceptibilities of 55 strains of Neisseria meningitidis isolated in Spain in 1993 and 1994. 1997 May-Jun Chemotherapy pmid:9142456
Ye Z and Van Dyke K Interaction of artemisinin and tetracycline or erythromycin against Plasmodium falciparum in vitro. 1994 Parasite pmid:9140487
Winkler M et al. [Incidence of inflammatory placental changes in threatened premature labor with and without additional antibiotic therapy]. 1997 Zentralbl Gynakol pmid:9139498
van Holten J et al. Neonatal Borrelia duttoni infection: a report of three cases. 1997 Trop Doct pmid:9133806
Furuya E Removal of interference by erythromycin, phenazopyridine, and methenamine mandelate in the Porter-Silber reaction. 1977 Clin. Chem. pmid:912880
Nakagawa A et al. A search for Pseudomonas alginate biosynthesis inhibitors from microbial metabolites. 1997 J. Antibiot. pmid:9127207
Jones RN and Biedenbach DJ Antimicrobial activity of RU-66647, a new ketolide. 1997 Jan-Feb Diagn. Microbiol. Infect. Dis. pmid:9127099
Langer JC and Bramlett G Effect of prokinetic agents on ileal contractility in a rabbit model of gastroschisis. 1997 J. Pediatr. Surg. pmid:9126764
Muranaka H et al. Superoxide scavenging activity of erythromycin-iron complex. 1997 Biochem. Biophys. Res. Commun. pmid:9125127
Roord JJ et al. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. 1996 Antimicrob. Agents Chemother. pmid:9124837
Müller M et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. 1996 Antimicrob. Agents Chemother. pmid:9124826
Atorvastatin--a new lipid-lowering drug. 1997 Med Lett Drugs Ther pmid:9121394
Samsom M et al. Effects of oral erythromycin on fasting and postprandial antroduodenal motility in patients with type I diabetes, measured with an ambulatory manometric technique. 1997 Diabetes Care pmid:9118759
Koley AP et al. Differential interaction of erythromycin with cytochromes P450 3A1/2 in the endoplasmic reticulum: a CO flash photolysis study. 1997 Biochemistry pmid:9116001
Leach AJ et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. 1997 Clin. Infect. Dis. pmid:9114185
Watanabe Y et al. [Relationship between quality and serum level after the oral administration of commercial erythromycin tablets in man (author's transl)]. 1977 Yakugaku Zasshi pmid:911413
Norinder A et al. Economic analysis of treatment with roxithromycin in comparison with erythromycin in patients with lower respiratory tract infections. 1997 Scand. J. Infect. Dis. pmid:9112304
Tarlow MJ Macrolides in the management of streptococcal pharyngitis/tonsillitis. 1997 Pediatr. Infect. Dis. J. pmid:9109157
McCracken GH Microbiologic activity of the newer macrolide antibiotics. 1997 Pediatr. Infect. Dis. J. pmid:9109155
Klein JO History of macrolide use in pediatrics. 1997 Pediatr. Infect. Dis. J. pmid:9109154
Monji H et al. Highly sensitive high-performance liquid chromatographic determination method for a new erythromycin derivative, EM523, and its major metabolites in human plasma and urine using post-column tris(2,2'-bipyridine) ruthenium(III) chemiluminescence detection. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9106057
Fietta A et al. Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. 1997 J Chemother pmid:9106014
Kato A [Effect of erythromycin and clarithromycin on ion transport across dissected canine tracheal epithelium]. 1997 Nippon Jibiinkoka Gakkai Kaiho pmid:9103848
Mikasa K et al. [Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer]. 1997 Nippon Naika Gakkai Zasshi pmid:9102408
Townsend GC and Mandell GL The new antibiotics, 1997. 1997 Va Med Q pmid:9100474
Göres E et al. [Animal experimental studies on the improvement of rectal absorption of chloramphenicol]. 1977 Pharmazie pmid:909908
Midolo PD et al. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro. 1997 J. Antimicrob. Chemother. pmid:9096182
Wilson WR Tetracyclines, chloramphenicol, erythromycin, and clindamycin. 1977 Mayo Clin. Proc. pmid:909315
Lerman SJ Prevention of rheumatic recurrence in the allergic, rheumatic fever patient. 1977 J. Pediatr. pmid:909037
Singh G et al. An audit of the problems in management of patients with gonorrhoea. 1997 Int J STD AIDS pmid:9089036
Sato F et al. EM574, an erythromycin derivative, is a motilin receptor agonist in the rabbit. 1997 Eur. J. Pharmacol. pmid:9088872